Vir Biotechnology logo

Vir Biotechnology share price today

(VIR)

Vir Biotechnology share price is $7.95 & ₹682.19 as on 7 Jan 2025, 2.30 'hrs' IST

$7.95

0.45

(6%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Vir Biotechnology share price in Dollar and Rupees. Guide to invest in Vir Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vir Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Vir Biotechnology share price movements

  • Today's Low: $7.67
    Today's High: $8.11

    Day's Volatility :5.38%

  • 52 Weeks Low: $6.56
    52 Weeks High: $13.09

    52 Weeks Volatility :49.89%

Vir Biotechnology Returns

PeriodVir Biotechnology IncSector (Health Care)Index (Russel 2000)
3 Months
2.46%
-8.4%
0.0%
6 Months
-10.39%
-3.8%
0.0%
1 Year
-27.4%
-0.1%
0.0%
3 Years
-77.56%
2.9%
-19.8%

Vir Biotechnology Key Statistics

in dollars & INR

Previous Close
$7.5
Open
$7.65
Today's High
$8.11
Today's Low
$7.6739
Market Capitalization
$1.0B
Today's Volume
$651.0K
52 Week High
$13.09
52 Week Low
$6.56
Revenue TTM
$78.6M
EBITDA
$-533.9M
Earnings Per Share (EPS)
$-3.93
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.59%
Return On Equity TTM
-36.58%

How to invest in Vir Biotechnology from India?

It is very easy for Indian residents to invest directly in Vir Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vir Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vir Biotechnology or VIR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vir Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vir Biotechnology shares which would translate to 0.108 fractional shares of Vir Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vir Biotechnology, in just a few clicks!

Returns in Vir Biotechnology for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vir Biotechnology investment value today

Current value as on today

₹80,183

Returns

₹19,817

(-19.82%)

Returns from Vir Biotechnology Stock

₹23,040 (-23.04%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Vir Biotechnology

-47%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Vir Biotechnology on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -47% less investors are searching Vir Biotechnology in the last 30 days versus the previous period.

Global Institutional Holdings in Vir Biotechnology

  • SB INVESTMENT ADVISERS (UK) LTD

    12.11%

  • BlackRock Inc

    11.93%

  • Vanguard Group Inc

    9.54%

  • State Street Corp

    4.08%

  • Orbimed Advisors, LLC

    2.59%

  • Baillie Gifford & Co Limited.

    1.73%

Analyst Recommendation on Vir Biotechnology

Buy

    69%Buy

    30%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Vir Biotechnology(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
4
4
4
Sell
0
0
0

Analyst Forecast on Vir Biotechnology

What analysts predicted

Upside of 271.07%

Current:

$7.95

Target:

$29.50

Insights on Vir Biotechnology

  • Price Movement

    In the last 1 month, VIR stock has moved down by -10.2%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 56.37M → 2.38M (in $), with an average decrease of 58.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -65.27M → -213.71M (in $), with an average decrease of 83.2% per quarter
  • VIR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 48.9%
  • VIR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 133.0%
  • Price to Sales

    ForVIR every $1 of sales, investors are willing to pay $13.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Vir Biotechnology Financials in INR & Dollars

FY18Y/Y Change
Revenue
$868.0K
↑ 482.55%
Net Income
$-115.9M
↑ 65.9%
Net Profit Margin
-13.4K%
↑ 33529.85%
FY19Y/Y Change
Revenue
$711.0K
↓ 18.09%
Net Income
$-174.7M
↑ 50.74%
Net Profit Margin
-24.6K%
↓ 11217.95%
FY20Y/Y Change
Revenue
$76.4M
↑ 10640.93%
Net Income
$-298.7M
↑ 70.98%
Net Profit Margin
-391.09%
↑ 24177.55%
FY21Y/Y Change
Revenue
$1.1B
↑ 1323.46%
Net Income
$528.6M
↓ 276.98%
Net Profit Margin
48.62%
↑ 439.71%
FY22Y/Y Change
Revenue
$1.6B
↑ 45.39%
Net Income
$515.8M
↓ 2.41%
Net Profit Margin
32.64%
↓ 15.98%
FY23Y/Y Change
Revenue
$86.2M
↓ 94.55%
Net Income
$-615.1M
↓ 219.24%
Net Profit Margin
-713.69%
↓ 746.33%
Q2 FY23Q/Q Change
Revenue
$-12.7M
↓ 127.23%
Net Income
$-194.8M
↑ 38.18%
Net Profit Margin
1.5K%
↑ 1832.77%
Q3 FY23Q/Q Change
Revenue
$-4.1M
↓ 67.79%
Net Income
$-163.4M
↓ 16.1%
Net Profit Margin
4.0K%
↑ 2456.62%
Q4 FY23Q/Q Change
Revenue
$16.8M
↓ 509.64%
Net Income
$-116.0M
↓ 29.03%
Net Profit Margin
-690.85%
↓ 4678.48%
Q1 FY24Q/Q Change
Revenue
$56.4M
↑ 235.83%
Net Income
$-65.3M
↓ 43.71%
Net Profit Margin
-115.79%
↑ 575.06%
Q2 FY24Q/Q Change
Revenue
$3.1M
↓ 94.55%
Net Income
$-138.4M
↑ 111.99%
Net Profit Margin
-4.5K%
↓ 4384.31%
Q3 FY24Q/Q Change
Revenue
$2.4M
↓ 22.6%
Net Income
$-213.7M
↑ 54.44%
Net Profit Margin
-9.0K%
↓ 4479.61%
FY18Y/Y Change
Profit
$-99.4M
↓ 66785.23%
FY19Y/Y Change
Profit
$711.0K
↓ 100.72%
FY20Y/Y Change
Profit
$76.4M
↑ 10640.93%
FY21Y/Y Change
Profit
$1.0B
↑ 1237.21%
FY22Y/Y Change
Profit
$1.4B
↑ 40.44%
FY23Y/Y Change
Profit
$83.4M
↓ 94.18%
Q2 FY23Q/Q Change
Profit
$-12.7M
↓ 128.44%
Q3 FY23Q/Q Change
Profit
$-4.1M
↓ 67.55%
Q4 FY23Q/Q Change
Profit
$11.5M
↓ 378.29%
Q1 FY24Q/Q Change
Profit
$51.8M
↑ 350.04%
Q2 FY24Q/Q Change
Profit
$-1.2M
↓ 102.39%
Q3 FY24Q/Q Change
Profit
$2.3M
↓ 288.36%
FY18Y/Y Change
Operating Cash Flow
$-94.1M
↑ 41.75%
Investing Cash Flow
$-60.4M
↑ 101.51%
Financing Cash Flow
$25.0M
↓ 90.79%
FY19Y/Y Change
Operating Cash Flow
$-129.6M
↑ 37.77%
Investing Cash Flow
$-256.2M
↑ 323.81%
Financing Cash Flow
$449.2M
↑ 1698.56%
FY20Y/Y Change
Operating Cash Flow
$-190.9M
↑ 47.29%
Investing Cash Flow
$-9.9M
↓ 96.15%
Financing Cash Flow
$529.5M
↑ 17.86%
FY21Y/Y Change
Operating Cash Flow
$-47.6M
↓ 75.08%
Investing Cash Flow
$-140.8M
↑ 1327.84%
Financing Cash Flow
$100.3M
↓ 81.05%
FY22Y/Y Change
Operating Cash Flow
$1.7B
↓ 3595.04%
Investing Cash Flow
$-1.2B
↑ 747.54%
Financing Cash Flow
$34.8M
↓ 65.35%
Q2 FY23Q/Q Change
Operating Cash Flow
$-389.2M
↑ 209.46%
Investing Cash Flow
$230.3M
↑ 134.83%
Financing Cash Flow
$3.2M
↑ 35.62%

Vir Biotechnology Technicals Summary

Sell

Neutral

Buy

Vir Biotechnology is currently in a neutral trading position according to technical analysis indicators.

Vir Biotechnology Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vir Biotechnology Inc
-13.99%
-10.39%
-27.4%
-77.56%
-40.66%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vir Biotechnology Inc
6.4
NA
NA
-3.92
-0.37
-0.19
NA
9.08
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vir Biotechnology Inc
Buy
$1.0B
-40.66%
6.4
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Vir Biotechnology

vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate. vir seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. the company will take a multi-program, multi-platform approach to applying these breakthroughs, guided by rigorous science and driven by medical need.
Organization
Vir Biotechnology
Employees
587
CEO
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
Industry
Commercial Services

Management People of Vir Biotechnology

NameTitle
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D.
CEO & Director
Dr. Ann M. Hanly Ph.D.
Executive VP & Chief Technology Officer
Dr. Jeff Calcagno M.D.
Executive VP & Chief Business Officer
Dr. Klaus Frueh Ph.D.
Co-Founder & Scientific Advisor
Dr. Lawrence Corey M.D.
Co-Founder & Scientific Advisor
Dr. Louis J. Picker M.D.
Co-Founder & Scientific Advisor
Mr. Jason O'Byrne
Executive VP & CFO
Mr. Brent Sabatini
Senior VP, Principal Accounting Officer & Chief Accounting Officer
Dr. Jennifer Eileen Towne Ph.D.
Executive VP & Chief Scientific Officer
Ms. Heather Rowe Armstrong
Vice President of Investor Relations

Important FAQs about investing in Vir Biotechnology from India :

What is Vir Biotechnology share price today?

Vir Biotechnology share price today stands at $7.95, Open: $7.65 ; Previous Close: $7.50 ; High: $8.11 ; Low: $7.67 ; 52 Week High: $13.09 ; 52 Week Low: $6.56. The stock opens at $7.65, after a previous close of $7.50. The stock reached a daily high of $8.11 and a low of $7.67, with a 52-week high of $13.09 and a 52-week low of $6.56.

Can Indians buy Vir Biotechnology shares?

Yes, Indians can invest in the Vir Biotechnology (VIR) from India.

With INDmoney, you can buy Vir Biotechnology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vir Biotechnology at zero transaction cost.

How can I buy Vir Biotechnology shares from India?

It is very easy to buy Vir Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vir Biotechnology be purchased?

Yes, you can buy fractional shares of Vir Biotechnology with INDmoney app.

What are the documents required to start investing in Vir Biotechnology stocks?

To start investing in Vir Biotechnology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vir Biotechnology

Today’s highest price of Vir Biotechnology (VIR) is $8.11.

Today’s lowest price of Vir Biotechnology (VIR) is $7.67.

What is today's market capitalisation of Vir Biotechnology

Today's market capitalisation of Vir Biotechnology VIR is 1.0B

What is the 52 Week High and Low Range of Vir Biotechnology

  • 52 Week High

    $13.09

  • 52 Week Low

    $6.56

What are the historical returns of Vir Biotechnology?

  • 1 Month Returns

    -13.99%

  • 3 Months Returns

    -10.39%

  • 1 Year Returns

    -27.4%

  • 5 Years Returns

    -40.66%

Who is the Chief Executive Officer (CEO) of Vir Biotechnology

Dr. Marianne De Backer M.B.A., M.Sc., Ph.D. is the current Chief Executive Officer (CEO) of Vir Biotechnology.